Cas:646459-41-8 646459-41-8 manufacturer & supplier

We serve Chemical Name:646459-41-8 CAS:646459-41-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

646459-41-8

Chemical Name:646459-41-8
CAS.NO:646459-41-8
Synonyms:6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine
Molecular Formula:C21H16ClN3O2S
Molecular Weight:409.89
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.349±0.06 g/cm3 (20 ºC 760 Torr)
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine Use and application,6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine technical grade,usp/ep/jp grade.


Related News: Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. 1-(2-Chloroethyl)piperazine manufacturers TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, (R)-Apremilast suppliers The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. Ubenimex Impurity 2 vendor & factory.